1834 Investment Advisors Co. Has $6.58 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

1834 Investment Advisors Co. reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 14.2% during the third quarter, Holdings Channel reports. The firm owned 11,256 shares of the healthcare conglomerate’s stock after selling 1,861 shares during the period. 1834 Investment Advisors Co.’s holdings in UnitedHealth Group were worth $6,581,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. International Assets Investment Management LLC lifted its position in shares of UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after buying an additional 5,290,025 shares during the last quarter. Swedbank AB bought a new stake in shares of UnitedHealth Group during the first quarter valued at about $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in shares of UnitedHealth Group by 107.8% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock worth $1,141,113,000 after purchasing an additional 1,196,758 shares during the period. Lone Pine Capital LLC bought a new stake in shares of UnitedHealth Group during the 2nd quarter valued at about $480,903,000. Finally, Dimensional Fund Advisors LP grew its stake in UnitedHealth Group by 30.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after buying an additional 880,183 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.6 %

Shares of NYSE UNH opened at $566.96 on Wednesday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $608.63. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market cap of $523.54 billion, a PE ratio of 36.94, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58. The business has a fifty day simple moving average of $580.96 and a two-hundred day simple moving average of $543.36.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same period in the prior year, the company posted $6.56 EPS. Analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.48%. UnitedHealth Group’s payout ratio is currently 54.72%.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the company. Wells Fargo & Company raised their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. TD Cowen raised their price target on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Hsbc Global Res cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 24th. Finally, Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and increased their price target for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.